Aggregation Mechanisms and Molecular Structures of Amyloid‐β in Alzheimer's Disease
Abstract: Amyloid plaques are a major pathological hallmark involved in Alzheimer's disease and consist of deposits of the amyloid‐β peptide (Aβ). The aggregation process of Aβ is highly complex, which leads to polymorphous aggregates with different structures. In addition to aberrant aggregation, Aβ oligomers can undergo liquid‐liquid phase separation (LLPS) and form dynamic condensates. It has been hypothesized that these amyloid liquid droplets affect and modulate amyloid fibril formation. In this review, we briefly introduce the relationship between stress granules and amyloid protein aggregation that is associated with neurodegenerative diseases. Then we highlight the regulatory role of LLPS in Aβ aggregation and discuss the potential relationship between Aβ phase transition and aggregation. Furthermore, we summarize the current structures of Aβ oligomers and amyloid fibrils, which have been determined using nuclear magnetic resonance (NMR) and cryo‐electron microscopy (cryo‐EM). The structural variations of Aβ aggregates provide an explanation for the different levels of toxicity, shed light on the aggregation mechanism and may pave the way towards structure‐based drug design for both clinical diagnosis and treatment.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Aggregation Mechanisms and Molecular Structures of Amyloid‐β in Alzheimer's Disease ; day:02 ; month:08 ; year:2024 ; extent:15
Chemistry - a European journal ; (02.08.2024) (gesamt 15)
- Urheber
- DOI
-
10.1002/chem.202400277
- URN
-
urn:nbn:de:101:1-2408031407200.710109334726
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Niu, Zheng
- Gui, Xinrui
- Feng, Shuang
- Reif, Bernd
Ähnliche Objekte (12)
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Bifurcations in coupled amyloid-β aggregation-inflammation systems
Co-aggregation with Apolipoprotein E modulates the function of Amyloid-β in Alzheimer’s disease
Influence of gold nanoparticle surface chemistry and diameter upon Alzheimer’s disease amyloid-β protein aggregation
The modulating effect of soluble amyloid-β dimers on amyloid-β aggregation in vivo and in vitro
Nanoscale structure of amyloid-β plaques in Alzheimer’s disease
Attenuated amyloid-β aggregation and neurotoxicity owing to methionine oxidation
β-Turn mimetic synthetic peptides as amyloid-β aggregation inhibitors
Clearance-Mechanismen von Amyloid-β bei der Alzheimer-Krankheit
Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer’s disease
Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease
Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Bifurcations in coupled amyloid-β aggregation-inflammation systems
Co-aggregation with Apolipoprotein E modulates the function of Amyloid-β in Alzheimer’s disease
Influence of gold nanoparticle surface chemistry and diameter upon Alzheimer’s disease amyloid-β protein aggregation
The modulating effect of soluble amyloid-β dimers on amyloid-β aggregation in vivo and in vitro
Nanoscale structure of amyloid-β plaques in Alzheimer’s disease
Attenuated amyloid-β aggregation and neurotoxicity owing to methionine oxidation
β-Turn mimetic synthetic peptides as amyloid-β aggregation inhibitors
Clearance-Mechanismen von Amyloid-β bei der Alzheimer-Krankheit
Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer’s disease
Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease
Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Bifurcations in coupled amyloid-β aggregation-inflammation systems
Co-aggregation with Apolipoprotein E modulates the function of Amyloid-β in Alzheimer’s disease
Influence of gold nanoparticle surface chemistry and diameter upon Alzheimer’s disease amyloid-β protein aggregation
The modulating effect of soluble amyloid-β dimers on amyloid-β aggregation in vivo and in vitro
Nanoscale structure of amyloid-β plaques in Alzheimer’s disease
Attenuated amyloid-β aggregation and neurotoxicity owing to methionine oxidation
β-Turn mimetic synthetic peptides as amyloid-β aggregation inhibitors
Clearance-Mechanismen von Amyloid-β bei der Alzheimer-Krankheit
Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer’s disease
Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease